Definitions
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- noun Plural form of
angioedema .
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word angioedemas.
Examples
-
In addition to its approved commercial use, DX-88 is also being evaluated for its therapeutic potential in other angioedema indications (acquired and ACE inhibitor-induced angioedemas) and, through a collaboration with Fovea Pharmaceuticals (a subsidiary of sanofi aventis), is in a Phase 1 trial for retinal vein occlusion-induced macular edema.
-
This four part strategy includes; first, Dyax's US commercialization of DX-88 in HAE, second the finalization of a European partnership for DX-88 in angioedemas, third DX-88's development and commercialization in surgical indications through our partnership with Cubist Pharmaceuticals, and finally the development of DX-88 in additional angioedemas, including nonhereditary angioedemas.
-
With respect to DX-88 in other angioedemas, we are pleased to announce the institutional review board approval was recently received for compassionate use of DX-88 in a study of patients with acquired angioedema.
-
With respect to DX-88 in other angioedemas, we are pleased to announce the institutional review board approval was recently received for compassionate use of DX-88 in a study of patients with acquired angioedema.
-
As we reported at the end of the quarter, while the exclusive negotiation period with Dompe for European partnership in DX-88 and angioedemas ended on September 30.
-
As we reported at the end of the quarter, while the exclusive negotiation period with Dompe for European partnership in DX-88 and angioedemas ended on September 30.
-
This four part strategy includes; first, Dyax's US commercialization of DX-88 in HAE, second the finalization of a European partnership for DX-88 in angioedemas, third DX-88's development and commercialization in surgical indications through our partnership with Cubist Pharmaceuticals, and finally the development of DX-88 in additional angioedemas, including nonhereditary angioedemas.
-
This four part strategy includes; first, Dyax's US commercialization of DX-88 in HAE, second the finalization of a European partnership for DX-88 in angioedemas, third DX-88's development and commercialization in surgical indications through our partnership with Cubist Pharmaceuticals, and finally the development of DX-88 in additional angioedemas, including nonhereditary angioedemas.
-
I think, other areas that we are still under active discussion and seeking input from experts in the field include that broad area of idiopathic angioedemas and here I am not talking about the allergic (inaudible) histamine of phenomenon but the ones that relate to a kallikrein pathway.
-
I think, other areas that we are still under active discussion and seeking input from experts in the field include that broad area of idiopathic angioedemas and here I am not talking about the allergic (inaudible) histamine of phenomenon but the ones that relate to a kallikrein pathway.
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.